openPR Logo
Press release

COVID-19 is Impact on Narcolepsy Drugs Market Target to Hit $5.36 billion by 2026, at CAGR of 10.3% | Ligand Pharmaceuticals, Addrenex Pharmaceuticals

08-07-2020 01:34 PM CET | Health & Medicine

Press release from: Allied Market Research

Narcolepsy Drugs Market

Narcolepsy Drugs Market

UPDATE AVAILABLE ON-DEMAND

The global narcolepsy drugs market generated $2,429 million in 2018, and is projected to reach $5,360 million by 2026, growing at a CAGR of 10.3% from 2019 to 2026.

Global Respiratory Care Devices Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/3612

The electroencephalography devices segment accounted for more than one-fifth of the total market share in 2017.

Narcolepsy is a chronic disabling condition with symptoms such as cataplexy, excessive daytime sleepiness (EDS), sleep paralysis, hypnogogic hallucinations, and disrupted nocturnal sleep. Most of the narcolepsy drugs are used to treat symptoms related to cataplexy and excessive daytime sleepiness.

The global narcolepsy drug market size has witnessed significant growth in the past few years, owing to rise in awareness regarding the benefits of early diagnosis of narcolepsy drug and availability of wide variety of narcolepsy drugs contribute toward the market growth. Governments of countries such as India and South Africa are promoting the awareness of importance of narcolepsy, which is further expected to boost the narcolepsy drug market growth during the forecast period. However, stringent government regulations toward the approval for novel narcolepsy drugs is projected to hamper the market growth during the forecast period. Conversely, untapped markets in the developing countries are expected to offer remunerative opportunities for the market players in the near future.

Based on narcolepsy disease type, the narcolepsy drugs market is segmented into daytime extreme sleepiness, cataplexia, and others. Daytime extreme sleepiness segment is the highest revenue generator in the overall narcolepsy drugs market, as large number of people suffering from narcolepsy and other sleep disorders have a higher risk of this symptom, thus increasing the demand for narcolepsy drugs. However, the cataplexia segment is expected to grow at the highest rate, as patients suffering from cataplexia experience loss of muscle control, and almost 70% of narcolepsy patients are found to have this symptom.

Based on therapeutics type, the narcolepsy drugs market is segmented into central nervous system stimulants, tricyclic antidepressants, sodium oxybate, selective serotonin reuptake inhibitor, and others. The sodium oxybate segment held the highest share global narcolepsy drugs market in the 2018, as these drugs are highly effective to treat daytime extreme sleepiness and cataplexy. However, selective serotonin reuptake inhibitor segment is expected to grow at the highest rate due to increase in R&D activities for the development of these type of drugs by the key players.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3612

The Major Key Players Are:

• Ligand Pharmaceuticals
• Addrenex Pharmaceuticals
• Shire Plc
• Teva Pharmaceutical Industries Ltd.
• Arena Pharmaceuticals
• Jazz Pharmaceuticals Plc
• Bioprojet
• Novartis

Key Findings of the Narcolepsy Drugs Market:

• Based on disease type, the cataplexia segment is expected to experience rapid growth in the market, and is projected to grow at a highest CAGR from 2019 to 2026.
• Depending on disease type, the daytime extreme sleepiness segment holds the highest share in 2018, and is anticipated to continue this trend during the forecast period.
• By therapeutics type, the sodium oxybate segment was the major revenue contributor in 2018, and is anticipated to continue this trend during the forecast period.
• Asia-Pacific region is anticipated to grow at high CAGR during the forecast period.

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 is Impact on Narcolepsy Drugs Market Target to Hit $5.36 billion by 2026, at CAGR of 10.3% | Ligand Pharmaceuticals, Addrenex Pharmaceuticals here

News-ID: 2106733 • Views: 215

More Releases from Allied Market Research

Airborne Fire Control Radar Market Global Business Outlook and Professional Surv …
A new report published by Allied Market Research, titled, “World Airborne Fire Control Radar Market by Frequency Band and Geography: Global Opportunity Analysis and Industry Forecast, 2014-2022,” forecasts that the world airborne fire control radar market is expected to reach $3,455 million by 2022, growing at a CAGR of 3.9% from 2016 to 2022. X-band segment is expected to witness highest growth rate, while region-wise North America is projected to
Aerospace Robotics Market Projected To Hit $5,687 Billion By 2022 | Analysis, Sa …
The aerospace robotics market in the LAMEA region is estimated to grow at a significant rate during the forecast period, owing to the heavy inflow of investment by the government to develop the aviation industry. Moreover, it is expected to witness significant growth in emerging countries such as Africa, Brazil, Iran, and Saudi Arabia. Download Sample Report: https://www.alliedmarketresearch.com/request-sample/2152 Aerospace Robotics Market Report, published by Allied Market Research, projects that the global
High Availability Server Market 2020 | Best Growth Opportunities to Generate Hug …
The Objective of the High Availability Server Market report is to depict the trends and upcoming for High Availability Server Industry over the forecast years. In High Availability Server Market report data has been gathered from industry specialists/experts. Although the market size of the market is studied and predicted from 2020 to 2027 mulling over 2019 as the base year of the market study. Attentiveness for the market has increased
U.S. Digital Therapeutics Market Expected to Reach $5.08 Billion by 2027
The U.S. digital therapeutics market is expected to grow at a faster rate during the forecast period, owing to increase in smartphone penetration in the U.S. Moreover, rise in need to curb healthcare costs and increase in prevalence of chronic diseases are anticipated to supplement the market growth. In addition, introduction of more sophisticated devices, which are compatible with smartphones and associated programs augments growth of the market. According to a

All 5 Releases


More Releases for Narcolepsy

A Comprehensive Study exploring Narcolepsy Therapeutics Market
A new research study from HTF MI with title Global Narcolepsy Therapeutics Market Size, Status and Forecast 2025 provides an in-depth assessment of the Narcolepsy Therapeutics including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Narcolepsy Therapeutics investments till 2025. Access Sample Copy @: https://www.htfmarketreport.com/sample-report/1181484-global-narcolepsy-therapeutics-market-4 If you are involved in the Narcolepsy Therapeutics industry or intend
Narcolepsy Market entry and market expansion strategies
MarketResearchReports.Biz adds “Global Narcolepsy Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Narcolepsy and the growth estimates for the forecasted period. GlobalData's clinical trial report, Narcolepsy Global Clinical Trials Review, H1, 2018" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of
Narcolepsy Treatment Pipeline Review H2 2017
Pune, India, 26th October 2017: WiseGuyReports announced addition of new report, titled “Narcolepsy - Pipeline Review, H2 2017”. Summary Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics
Narcolepsy Market Pipeline Review, H2 2017
"The Report Narcolepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime
Narcolepsy Drug Market Size 2017-2022 Novartis, Mylan, Teva Pharmaceutical
In the last several years, global market of narcolepsy drug developed rapidly, with an average growth rate of 9.6%. In 2016, global revenue of narcolepsy drug is nearly 1725 M USD; the actual production is about 48380 Kg. The global average price of narcolepsy drug is in the decreasing trend, from 43.3 K USD/Kg in 2012 to 35.7 K USD/Kg in 2016. With the situation of global economy, prices will
Narcolepsy - Pipeline Review, H1 2017 - Pharmaceutical Report
Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1068443 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Narcolepsy (Central Nervous System), complete